Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL8845141

N.c1cc2cc3c(cc2o1)CCCC3

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 3/20 0.40
HSD17B10 Q99714 2/20 0.40
KDM4E B2RXH2 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
NFKB1 P19838 1/20 0.40
MAOA P21397 1/20 0.40
ACHE P22303 1/20 0.40
CYP2C19 P33261 1/20 0.40
DYRK1A Q13627 3/20 0.35
CDK9 P50750 1/20 0.34
HTR1B P28222 8/20 0.34
HTT P42858 2/20 0.33
NPC1 O15118 1/20 0.33
TP53 P04637 1/20 0.33
PKM P14618 1/20 0.33
STAT1 P42224 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6947277 0.98 CYP2A6 (0.41) CYP2A6HSD17B10KDM4ECYP3A4CYP2D6
SCHEMBL10334537 0.96 CYP2A6 (0.40) CYP2A6HSD17B10KDM4ECYP3A4CYP2D6
SCHEMBL6952322 0.94 CYP2A6 (0.41) CYP2A6HSD17B10KDM4ECYP3A4CYP2D6
SCHEMBL12105398 0.80 HTR2C (0.50) CYP2A6HSD17B10KDM4ECYP3A4CYP2D6
SCHEMBL9672219 0.76 MAOA (0.46) CYP2A6HSD17B10KDM4ECYP3A4CYP2D6
SCHEMBL25592162 0.75 CYP2A6 (0.41) CYP2A6HSD17B10KDM4ECYP3A4CYP2D6
SCHEMBL9670865 0.74 MAOA (0.45) CYP2A6HSD17B10KDM4ECYP3A4CYP2D6
SCHEMBL2149910 0.74 CYP2A6 (0.54) CYP2A6HSD17B10KDM4ECYP3A4CYP2D6
SCHEMBL6052782 0.73 CYP2A6 (0.47) CYP2A6HSD17B10KDM4ECYP3A4CYP2D6
SCHEMBL9671842 0.73 ACHE (0.38) CYP2A6HSD17B10KDM4ECYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5665765-A TREATMENT OF PARKINSON'S DISEASE, MEMORY DISORDERS, DISORDERS ASSOCIATED WITH DRUG ABUSE, DEPRESSION, AND PSYCHOTIC STATES ADIR ET COMPAGNIE (FR) 1997-09-09 US disclosed